SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RCMac who wrote (1604)10/13/2003 11:36:24 AM
From: Biomaven  Read Replies (1) of 3158
 
Thanks, Bob. But it's still not altogether clear whether a prospective muncher might not feel they were pushing the envelope if they were to acquire the converts ahead of any filing.

Note that for the executive proxy rules disclosure, execs have to disclose their direct holdings and also how many options are exercisable by them within 60 days, irrespective of whether the options are in-the-money or not. So there is some precedent for disregarding the exercise price in a related disclosure area.

But clearly it can't hurt to keep an eye on these prices - a surge in the convert price might well be very revealing.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News